SNY Stock: Price, Earnings History and SEC Filings
Sanofi (SNY) last traded at $44.34, up 2.81% on the latest session and up 7.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.21 against an analyst estimate of $1.10, a beat of 10.0%.
$44.34 +2.81%
1 month+7.54%
52-week high$52.68
52-week low$39.07
Volume15.10M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
SNY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 30, 2026 | $1.21 | $1.10 | +10.00% |
| Mar 2026 | Apr 23, 2026 | $1.10 | $1.06 | +3.77% |
| Dec 2025 | Jan 29, 2026 | $0.89 | $0.84 | +5.95% |
| Sep 2025 | Oct 24, 2025 | $1.70 | $1.60 | +6.25% |
SNY beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for SNY
SEC filing data is not available right now. You can search for SNY on SEC EDGAR.
SNY news
- Sanofi (ENXTPA:SAN) Stock Can Q3 Earnings Sustain Its Revenue StrengthNov 1, 2026 · finance.yahoo.com
- Regeneron: 3 Key Takeaways for Long-Term InvestorsOct 31, 2026 · fool.com
- Regeneron Stock Just Hit a 2-Year High. Here's Why.Oct 31, 2026 · barchart.com
- Regeneron (REGN) stock trades up, here is whyOct 31, 2026 · finance.yahoo.com
- EssilorLuxottica Stock And Eurozone Healthcare Giants Worth Watching NowOct 30, 2026 · finance.yahoo.com
- Regeneron Bolts 13% Higher, Breaking Out To A Two-Year High On Dupixent DominanceOct 30, 2026 · finance.yahoo.com
- Regeneron Pharmaceuticals, Inc. Q3 2026 Earnings Call SummaryOct 30, 2026 · app.moby.co
- Sanofi Q3 Earnings Call HighlightsOct 30, 2026 · marketbeat.com
About Sanofi
Sanofi (SNY) is a US-listed public company on Nasdaq.